Financial calendar

29.May 19

Annual general meeting

22.Aug 19

Semi-annual Report Q2, 2019

21.Nov 19

Quarterly statement Q3, 2019

Quarterly statement Q3, 2019

Scandion Oncology Investor Relations

Nils Brünner, CEO
E: nb@scandiononcology.com
T: +45 26144708

Investor Relations

Spotlight
Waterfront Building
Klarabergsviadukten 63, 9 tr
101 23 Stockholm
Sweden

Phone: +46 8 511 68 000
Website: www.spotlightstockmarket.com

Qualified Adviser

Sedermera Fondkommission
Norra Vallgatan 64
211 22 Malmö
Sweden

Phone: + 46 406151410
Website: www.sedermera.se

Privacy and Cookie Policy